ATE298423T1 - METHOD FOR INHIBITING THE DEGRADATION OF NATRIURETIC PEPTIDES AND IMPROVED METHOD FOR DETERMINING NATRIURETIC PEPTIDES - Google Patents

METHOD FOR INHIBITING THE DEGRADATION OF NATRIURETIC PEPTIDES AND IMPROVED METHOD FOR DETERMINING NATRIURETIC PEPTIDES

Info

Publication number
ATE298423T1
ATE298423T1 AT98911128T AT98911128T ATE298423T1 AT E298423 T1 ATE298423 T1 AT E298423T1 AT 98911128 T AT98911128 T AT 98911128T AT 98911128 T AT98911128 T AT 98911128T AT E298423 T1 ATE298423 T1 AT E298423T1
Authority
AT
Austria
Prior art keywords
natriuretic peptides
inhibiting
degradation
peptides
determining
Prior art date
Application number
AT98911128T
Other languages
German (de)
Inventor
Hiroyuki Shimizu
Hidehisa Asada
Kazuaki Endo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17788947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE298423(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE298423T1 publication Critical patent/ATE298423T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for inhibiting the degradation of mammalian natriuretic peptides, in particular, BNP by using containers wherein the face coming into contact with specimens are made of a material capable of inhibiting the activation of a substance degrading peptides. This method makes it possible to collect specimens for measuring natriuretic peptides stably and conveniently . Also provided is a method for measuring natriureitc peptides by using these containers.
AT98911128T 1997-10-24 1998-03-31 METHOD FOR INHIBITING THE DEGRADATION OF NATRIURETIC PEPTIDES AND IMPROVED METHOD FOR DETERMINING NATRIURETIC PEPTIDES ATE298423T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29298297 1997-10-24
PCT/JP1998/001470 WO1999022235A1 (en) 1997-10-24 1998-03-31 Method for inhibiting decomposition of natriuretic peptides and improved method for assaying natriuretic peptides with the use of the same

Publications (1)

Publication Number Publication Date
ATE298423T1 true ATE298423T1 (en) 2005-07-15

Family

ID=17788947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98911128T ATE298423T1 (en) 1997-10-24 1998-03-31 METHOD FOR INHIBITING THE DEGRADATION OF NATRIURETIC PEPTIDES AND IMPROVED METHOD FOR DETERMINING NATRIURETIC PEPTIDES

Country Status (11)

Country Link
US (1) US7534582B2 (en)
EP (1) EP1030177B2 (en)
JP (1) JP3302376B2 (en)
KR (1) KR100529198B1 (en)
CN (1) CN1149396C (en)
AT (1) ATE298423T1 (en)
AU (1) AU751660B2 (en)
CA (1) CA2306751C (en)
DE (1) DE69830668T3 (en)
ES (1) ES2244052T5 (en)
WO (1) WO1999022235A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2430889A1 (en) * 2002-06-19 2003-12-19 Bayer Corporation Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
CA2504287A1 (en) 2002-11-26 2004-06-10 Nobex Corporation Natriuretic compounds, conjugates, and uses thereof
US7445933B2 (en) 2003-07-16 2008-11-04 Abbott Laboratories, Inc. Stable calibrators or controls for measuring human natriuretic peptides
US7291501B2 (en) 2003-07-16 2007-11-06 Abbott Laboratories Stable compositions for measuring human natriuretic peptides
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
US7731965B2 (en) 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
JP2010091398A (en) * 2008-10-08 2010-04-22 Tosoh Corp Stable natriuretic peptide composition
US9274126B2 (en) * 2009-11-13 2016-03-01 Bg Medicine, Inc. Risk factors and prediction of myocardial infarction
CN113671197B (en) * 2021-08-19 2023-08-08 四川沃文特生物技术有限公司 Buffer solution, calibrator, kit, preparation method and application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057495A (en) 1988-06-24 1991-10-15 Queen's University At Kingston Atrial hypotensive peptide
JPH0667319B2 (en) 1989-04-19 1994-08-31 塩野義製薬株式会社 Monoclonal antibody that recognizes the C-terminal side of ANP
JPH0748071B2 (en) 1989-05-31 1995-05-24 株式会社ミドリ十字 hANP antibody and immunoassay for hANP
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
JPH08178926A (en) 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd Immunoassay plate and use thereof

Also Published As

Publication number Publication date
US7534582B2 (en) 2009-05-19
KR20010031392A (en) 2001-04-16
ES2244052T5 (en) 2011-03-28
WO1999022235A1 (en) 1999-05-06
ES2244052T3 (en) 2005-12-01
CA2306751A1 (en) 1999-05-06
EP1030177B1 (en) 2005-06-22
JP3302376B2 (en) 2002-07-15
US20070196888A1 (en) 2007-08-23
AU751660B2 (en) 2002-08-22
DE69830668T2 (en) 2006-05-04
DE69830668D1 (en) 2005-07-28
CA2306751C (en) 2006-12-12
EP1030177B2 (en) 2010-12-08
KR100529198B1 (en) 2005-11-17
AU6520898A (en) 1999-05-17
DE69830668T3 (en) 2011-07-14
EP1030177A1 (en) 2000-08-23
CN1149396C (en) 2004-05-12
CN1283269A (en) 2001-02-07
EP1030177A4 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
ATE298423T1 (en) METHOD FOR INHIBITING THE DEGRADATION OF NATRIURETIC PEPTIDES AND IMPROVED METHOD FOR DETERMINING NATRIURETIC PEPTIDES
PT1137941E (en) Protein scaffolds for antibody mimics and other binding proteins
DE60040333D1 (en) METHOD FOR ACYLATING PEPTIDES AND PROTEINS
DK169724B1 (en) Method for Preparing a Factor VIII: C Polypeptide Fragment, Coding DNA Sequence, and Extrachromosomal Element Containing Such a DNA Sequence
AU4185001A (en) Protein scaffolds for antibody mimics and other binding proteins
EP0293443A4 (en) Construction of synthetic dna and its use in large polypeptide synthesis.
ATE188994T1 (en) METHODS FOR TRANS-DESTABILIZATION OF SPECIFIC PROTEINS IN VIVO
EP2275818A3 (en) Method for improved early recognition of the seroconversion of an antibody to hepatitis C
DE69841037D1 (en) CHARACTERIZATION OF GRANULOCYTIC EHRLICHIA AND METHODS OF THEIR USE.
ATE425764T1 (en) USE OF IGF-1 ALONE OR COMBINED WITH GROWTH FACTOR TO STIMULATE GROWTH
ATE165363T1 (en) METHOD AND MEANS FOR SORTING AND DETERMINING BIOLOGICAL INFORMATION
ATE152481T1 (en) NEW POLYPEPTIDES, DNA SEQUENCES ALLOWING THEIR EXPRESSION, METHOD OF PREPARATION AND USE
DE69515416D1 (en) Procedure for the detection of interferon activity
ATE432287T1 (en) PEPTIDE FRAGMENTS WITH CELL DEATH PREVENTING ACTIVITY
ATE417068T1 (en) SUBSTANCE HAVING ANTITHROMBOTIC ACTIVITY AND METHOD FOR DETERMINING GLYCOCALLIDIN
GB9816514D0 (en) Novel method
ATE111918T1 (en) SPECIFIC CLEAVAGE OF PEPTIDE BONDS BY ORGANIC TERTIARY PHOSPHINES WITH NUCLEOPHILIC SIDE CHAINS.
ATE142224T1 (en) SM-D ANTIGEN PEPTIDES, THEIR USE FOR DETECTING DISSEMINATED LUPUS-ERYTHEMATEUX
DE69837399D1 (en) PROCESS FOR SCREENING TGF-BETA INHIBITED SUBSTANCES
DE3873273D1 (en) METHOD FOR SELECTIVE CLEAVAGE OF FUSION PROTEINS.
ATE171483T1 (en) ELECTROLYSIS CELL AND METHOD FOR LABELING PROTEINS AND PEPTIDES
DE68913446D1 (en) Apparatus for the determination of two substances using enzyme electrodes and method for carrying out this determination.
IT1277057B1 (en) IMPROVED ANTIGENIC PEPTIDES
IL95738A0 (en) Antibodies against highly conserved amino acid sequences of immunogenic substances,a process for the preparation of these antibodies and the use thereof in immunoassays

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties